Patient Recruitment and Enrollment in Clinical Trials

Recruiting participants for clinical trials is frequently a bigger challenge than conducting the trials themselves. A delay in recruitment extends the study's timeline, pushing back the treatment's market availability. Check out the infographic below to understand how the public discovers clinical trials, motivations for participation, and the hurdles faced in enrollment.

Patient Recruitment and Enrollment Infographic

Discovering Clinical Trials

72% of participants are existing patients, while twenty-eight percent are new.
Top sources of clinical trial information:
58% from primary care physicians
40% from online registries
Thirty percent from search engines
19% from primary care nurses
19% from pharmaceutical companies
Motivations for Participation

Top perceived benefits:
Twenty-six percent to advance medicine
Thirty-six percent to improve others' lives
15% to improve their condition
8% here as the best treatment option
Five percent for monetary compensation
Factors influencing participation:
Sixty percent physical location
63% confidentiality
73% types of procedures
Seventy-five percent study purpose
Eighty-three percent potential risks and benefits
Enrollment Challenges

37% of sites under-enroll, with 11% failing to enroll any patients.
Doubling original timelines helps ninety percent of trials meet enrollment goals.
Seventy percent of the public haven't considered clinical trials, with 19% unwilling to participate and seven percent unsure.
Top perceived risks:
Forty percent side effects
33% overall health risks
7% receiving placebo
7% stopping beneficial treatments
Forty percent lack confidence in finding a suitable study, and seventy percent seldom consider clinical trials when discussing treatment options.
However, there's optimism for improvement: 74% are open to discussing trial participation in online peer communities, and 94% of volunteers would participate again.

To learn more visit our website at

Patient Recruitment and Enrollment in Clinical Trials

Leave a Reply

Your email address will not be published. Required fields are marked *